Publicacións nas que colabora con Antonio Aguilera Guirao (28)

2023

  1. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

  2. The interaction between liver cirrhosis, infection by Streptococcus bovis, and colon cancer

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 42, Núm. 7, pp. 907-912

2022

  1. Ten steps to eliminating hepatitis C in hospitals

    Nature Reviews Gastroenterology and Hepatology

2020

  1. Executive summary: Consensus document of the diagnosis, management and prevention of infection with the hepatitis E virus: Study Group for Viral Hepatitis (GEHEP) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 1, pp. 28-32

2019

  1. Correlation between Streptococcus bovis bacteremia and density of cows in Galicia, northwest of Spain

    Infection, Vol. 47, Núm. 3, pp. 399-407

2018

  1. Meningitis due to autochthonous acute infection with hepatitis E virus in a chef: A case report

    Journal of Antimicrobial Chemotherapy

2017

  1. Rate and predictors of treatment failure to all-oral HCV regimens outside clinical trials

    Antiviral Therapy, Vol. 22, Núm. 4, pp. 307-312

2016

  1. Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe

    Clinical Infectious Diseases, Vol. 62, Núm. 5, pp. 655-663

2015

  1. Molecular characterization of HIV-1 infection in Northwest Spain (2009-2013): Investigation of the subtype F outbreak

    Infection, Genetics and Evolution, Vol. 30, pp. 96-101

  2. Virological failure to raltegravir in Spain: Incidence, prevalence and clinical consequences

    Journal of Antimicrobial Chemotherapy, Vol. 70, Núm. 11, pp. 3087-3095

2014

  1. HIV-2 viral tropism influences CD4+ T cell count regardless of viral load

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 8, pp. 2191-2194

2013

  1. Influence of HIV infection on response to tenofovir in patients with chronic hepatitis B

    AIDS, Vol. 27, Núm. 14, pp. 2219-2224

  2. Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

    AIDS, Vol. 27, Núm. 1, pp. 81-85

2012

  1. Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

    Retrovirology, Vol. 9

2006

  1. Isolation and biological characterization of HIV-1 BG intersubtype recombinants and other genetic forms circulating in Galicia, Spain

    Journal of Medical Virology, Vol. 78, Núm. 12, pp. 1520-1528

2005

  1. Association of hepatitis A virus infection with allergic sensitization in a population with high prevalence of hepatitis A virus exposure

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 60, Núm. 1, pp. 98-103

  2. Molecular epidemiology of HTLV-2 infection among intravenous drug users in Spain

    Journal of Clinical Virology, Vol. 33, Núm. 1, pp. 65-70

2004

  1. Total HCV core antigen assay: A new marker of HCV viremia and its application during treatment of chronic hepatitis C

    Journal of Virological Methods, Vol. 120, Núm. 2, pp. 173-177

  2. Truly de novo Hepatitis B after Liver Transplantation [6]

    American Journal of Gastroenterology

2003

  1. Association of HCV and HBV Markers in Spanish HIV-seropositive Patients in relation to Risk Practices

    Hepato-Gastroenterology, Vol. 50, Núm. 54, pp. 2093-2097